These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 2824117)

  • 1. Ageing and the alpha 2-adrenergic system of the platelet.
    Davis PB; Silski C
    Clin Sci (Lond); 1987 Nov; 73(5):507-13. PubMed ID: 2824117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The alpha 2-adrenergic system of the platelet in cystic fibrosis.
    Davis PB; Dieckman L; Boat TF; Stern RC; Doershuk CF
    Am J Med Sci; 1984 Oct; 288(3):104-8. PubMed ID: 6091455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha 2-adrenoceptor coupling to adenylate cyclase in adrenaline insensitive human platelets.
    Swart SS; Maguire M; Wood JK; Barnett DB
    Eur J Pharmacol; 1985 Oct; 116(1-2):113-9. PubMed ID: 2996911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: inhibition of cyclic AMP breakdown by cyclic GMP.
    Maurice DH; Haslam RJ
    Mol Pharmacol; 1990 May; 37(5):671-81. PubMed ID: 2160060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional uncoupling of the platelet alpha 2-adrenergic receptor-adenylate cyclase complex in the elderly.
    Supiano MA; Linares OA; Halter JB; Reno KM; Rosen SG
    J Clin Endocrinol Metab; 1987 Jun; 64(6):1160-4. PubMed ID: 3033007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of clomipramine treatment on dog platelet alpha 2-adrenergic receptivity.
    Villeneuve A; Berlan M; Paris H; Tran MA; Lafontan M; Montastruc JL; Montastruc P
    J Pharmacol; 1986; 17(4):644-50. PubMed ID: 3031380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet alpha-adrenergic binding and biochemical responsiveness in depressed patients and controls.
    Siever LJ; Kafka MS; Targum S; Lake CR
    Psychiatry Res; 1984 Apr; 11(4):287-302. PubMed ID: 6330782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced cyclic AMP production in the blood platelets from schizophrenic patients.
    Kafka MS; van Kammen DP; Bunney WE
    Am J Psychiatry; 1979 May; 136(5):685-7. PubMed ID: 219720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of activation of protein kinase C on the agonist-induced stimulation and inhibition of cyclic AMP formation in intact human platelets.
    Williams KA; Murphy W; Haslam RJ
    Biochem J; 1987 May; 243(3):667-78. PubMed ID: 2444206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha-adrenergic responses in asthma.
    Davis PB; Paget GL; Turi V
    J Lab Clin Med; 1985 Feb; 105(2):164-9. PubMed ID: 2857756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet alpha-adrenoceptor function and aging.
    Winther K; Naesh O
    Thromb Res; 1987 Jun; 46(5):677-84. PubMed ID: 2820076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of berberine with human platelet alpha 2 adrenoceptors.
    Hui KK; Yu JL; Chan WF; Tse E
    Life Sci; 1991; 49(4):315-24. PubMed ID: 1649363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha 2-adrenergic receptor-mediated regulation of adenylate cyclase in the intact human platelet. Evidence for a receptor reserve.
    Lenox RH; Ellis J; Van Riper D; Ehrlich YH
    Mol Pharmacol; 1985 Jan; 27(1):1-9. PubMed ID: 2981397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Examination of the role of inhibition of cyclic AMP in alpha 2-adrenoceptor mediated contractions of the porcine isolated palmar lateral vein.
    Wright IK; Harling R; Kendall DA; Wilson VG
    Br J Pharmacol; 1995 Jan; 114(1):157-65. PubMed ID: 7712012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developmental Differences in Platelet Inhibition Response to Prostaglandin E1.
    Palma-Barqueros V; Torregrosa JM; Caparrós-Pérez E; Mota-Pérez N; Bohdan N; Llanos MDC; Begonja AJ; Sola-Visner M; Vicente V; Teruel-Montoya R; Rivera J; Ferrer-Marín F
    Neonatology; 2020; 117(1):15-23. PubMed ID: 31786577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aging and platelet beta-adrenoceptor function.
    Winther K; Naesh O
    Eur J Pharmacol; 1987 Apr; 136(2):219-23. PubMed ID: 3036547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down regulation of alpha 2 adrenergic receptor numbers in platelets by insulin.
    Kahn NN; Sinha AK
    Biochim Biophys Acta; 1992 Apr; 1134(3):292-6. PubMed ID: 1313699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of adenyl-cyclase activators, phosphodiesterase inhibitors and pyridoxal-5-phosphate on platelet aggregation and adenosine-3'-5'-cyclic monophosphate accumulation.
    Zahavi M; Zahavi J; Kakkar VV
    Thromb Haemost; 1984 Oct; 52(2):205-9. PubMed ID: 6098048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of nitrovasodilators on platelet cyclic nucleotide levels in rabbit blood; role for cyclic AMP in synergistic inhibition of platelet function by SIN-1 and prostaglandin E1.
    Bowen R; Haslam RJ
    J Cardiovasc Pharmacol; 1991 Mar; 17(3):424-33. PubMed ID: 1711604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of adenylate cyclase by adenosine analogues in preparations of broken and intact human platelets. Evidence for the unidirectional control of platelet function by cyclic AMP.
    Haslam RJ; Davidson MM; Desjardins JV
    Biochem J; 1978 Oct; 176(1):83-95. PubMed ID: 215136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.